1.91 billion
Myocardial Infarction (MI) Therapeutics Market Size, Share, Growth Analysis, By Treatment/Drug Type(Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers), By Route of Administration(Oral, Injectable), By Distribution Channel(Offline drug stores (Retail Pharmacies, Hospital Pharmacies), Online drug stores), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35I2029 |
Region:
Global |
Published Date: October, 2024
Pages:
257
|Tables:
95
|Figures:
70
Myocardial Infarction (MI) Therapeutics Market Insights
Myocardial Infarction (MI) Therapeutics Market size was valued at around USD 2.20 billion in 2022 and is expected to rise from USD 2.31 billion in 2023 to reach a value of USD 3.36 billion by 2031, at a CAGR of 4.82% over the forecast period (2024–2031).
The main cause of myocardial infarction, often known as a heart attack, is coronary artery disease, which results in a decreased blood flow to the heart muscles. Myocardial infarction happens when an area of the heart loses oxygen because one of the coronary arteries is blocked. Typically, blockages form as a result of atherosclerotic plaque accumulation on artery walls. The septal, anterior, posterior, lateral, or inferior walls of the left ventricle of the heart are where myocardial infarctions are most often found. Thus, insufficient oxygen results in the death of cardiac tissue and a recognisable chest discomfort in humans, which causes myocardial infarction. Around 17.3 million people worldwide pass away from heart disease each year, with myocardial infarction being the main cause of death, according to the American Heart Association (AHA). This increases the requirement of treatments for myocardial infarction which leads to the growth of the myocardial infarction (MI) therapeutics market.
The growth of the market for myocardial infarction treatment is also due to the rising prevalence of cardiovascular disorders and the growing senior population. The increased frequency of obesity and chronic disorders like diabetes, hypertension, and chronic kidney disease are further reasons driving this market's expansion. Additionally, unhealthy lifestyle habits, excessive alcohol consumption, and drug use—including amphetamine and cocaine use—among the populace are significant risk factors for myocardial infarction. As a result, the market for myocardial infarction treatment and management products is expected to grow in the coming years. According to estimates, the global market for myocardial infarction treatments has the potential to be lucrative and to grow due to the rising popularity of efficient and secure treatment protocols. The market for myocardial infarction treatments may develop as a result of anticipated technology advancements that will create a plethora of chances for detecting specific blockages, monitoring cellular response, and determining hereditary predisposition.
US Myocardial Infarction (MI) Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024–2031
Global Market Size
Largest Segment
Offline Drug Store
Fastest Growth
Offline Drug Store
Growth Rate
4.82% CAGR
Global Myocardial Infarction (MI) Therapeutics Market 2024-2031 ($ Bn)
Country Share for North America Region- 2024-2031 (%)
To get more reports on the above market click here to Buy The Report
Myocardial Infarction (MI) Therapeutics Market Segmental Analysis
The Global Myocardial Infarction (MI) Therapeutics Market is segmented based on treatment/drug type, route of administration, distribution channel, and region. Based on Treatment/Drug Type, Myocardial Infarction (MI) Therapeutics Market is categorized into Antiplatelet Agents, Glycoprotein IIb/IIIa Inhibitors, Antithrombotic Agents, Beta-adrenergic Blockers, Vasodilators, Angiotensin-converting Enzyme (ACE) Inhibitors, Angiotensin-receptor Blockers, Analgesics and Thrombolytics. Based on the Route of Administration, Myocardial Infarction (MI) Therapeutics Market is categorized into Oral, and Injectable. Based on the Distribution Channel, Myocardial Infarction (MI) Therapeutics Market is categorized into Offline drug stores and Online drug stores. The Offline drug store segment is further sub-segmented into Retail Pharmacies, and Hospital Pharmacies. Based on region, Myocardial Infarction (MI) Therapeutics Market is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.
Myocardial Infarction (MI) Therapeutics Market Analysis by Distribution Channel
On the basis of distribution channel, the hospital pharmacy segment is currently dominating the global myocardial infarction (MI) therapeutics market. Majority of the population turns to hospitals in case of emergencies such as the myocardial infarction due the easy access and availability of hospital services. This contributes to the growth of the hospitals and hospital pharmacies segment significantly in the global market for MI therapeutics.
Global Myocardial Infarction (MI) Therapeutics Market By Distribution Channel, 2024-2031(%)
To get detailed analysis on other segments, Request For Free Sample Report
Myocardial Infarction (MI) Therapeutics Market Regional Insights
Based on the region, the North American region currently dominates the global myocardial infarction (MI) therapeutics market. This is due to the rising prevalence of cardiovascular disorders and the growing senior population, that the market for myocardial infarction treatment is expanding admirably in this region. The increased frequency of obesity and chronic disorders like diabetes, hypertension, and chronic kidney disease are further reasons driving this market's expansion. Additionally, unhealthy lifestyle habits, excessive alcohol consumption, and drug use—including amphetamine and cocaine use—among the populace are significant risk factors for myocardial infarction. As a result, the market for myocardial infarction treatment and management products is expected to grow in the coming years. According to estimates, the global market for myocardial infarction treatments has the potential to be lucrative and to grow due to the rising popularity of efficient and secure treatment protocols. The market for myocardial infarction treatments may develop as a result of anticipated technology advancements that will create a plethora of chances for detecting specific blockages, monitoring cellular response, and determining hereditary predisposition.
Global Myocardial Infarction (MI) Therapeutics Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Myocardial Infarction (MI) Therapeutics Market Dynamics
Myocardial Infarction (MI) Therapeutics Market Drivers
- The global myocardial infarction market is projected to increase as heart attacks become more common. Apart from this, the two main drivers anticipated to propel the growth of the global market for myocardial infarction therapies are the rising incidence of coronary artery disease and changes in lifestyle. Over the forecast period, rising blood pressure, obesity, and smoking rates, among other factors, are predicted to propel the global market for myocardial infarction treatments.
Myocardial Infarction (MI) Therapeutics Market Restraints
- The primary inhibitors for the global market for myocardial infarction treatments are the increased cost of research and development and the restricted R&D Activities. Other market-restraining factors that could hamper the growth of the myocardial infarction therapeutics market in the upcoming years include the rise in overall healthcare spending, strict regulatory rules, and high expenditures of clinical trials.
Request Free Customization of this report to help us to meet your business objectives.
Myocardial Infarction (MI) Therapeutics Market Competitive Landscape
Due to the presence of numerous established as well as new businesses in this sector, the market for myocardial infarction treatments is extremely fragmented and established. It is expected that new competitors will attempt to enter this market in the near future due to the rising incidence and prevalence of acute myocardial infarction and other cardiovascular disorders.
Myocardial Infarction (MI) Therapeutics Market Top Players Company Profiles
- Bayer HealthCare LLC (Germany)
- Daiichi Sankyo, Inc. (Japan)
- Eli Lilly and Company (US)
- Janssen Biotech, Inc. (US)
- Merck & Co. Inc. (US)
- Novartis International AG (Switzerland)
- Sanofi (France)
- AstraZeneca (UK)
- Pfizer (US)
- Amgen, Inc (US)
- GlaxoSmithKline PLC (UK)
- Regeneron Pharmaceuticals Inc. (US)
- Bristol-Myers Squibb Company (US)
- Alnylam Pharmaceuticals Inc. (US)
Myocardial Infarction (MI) Therapeutics Market Recent Developments
- In May 2021, Recardio Inc., a clinical-stage life science firm specializing in regenerative therapeutics for cardiovascular disorders, finished its Phase 2 randomized, double-blind, placebo-controlled, safety, and efficacy study of dutogliptin combined with filgrastim in early recovery post-myocardial infarction.
- In May 2020, Eli Lilly and Company, Boehringer Ingelheim, and the Duke Clinical Research Institute (DCRI) collaborated on academic research for the new study of EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction).
Myocardial Infarction (MI) Therapeutics Key Market Trends
- The delivery of medications and imaging probes using nanoparticle technology offers new approaches for the treatment of cardiovascular disease (CVD). With significant efforts being made to address therapy possibilities for myocardial infarction (MI), advancements in the production of nanoparticles, their design characteristics, and functional diversity have permitted its direct implementation in preclinical CVD research. It is possible to create nanocarrier systems with efficient cell-, tissue-, or disease-specific and targeted actions through the rational design of nanoparticles, resolving problems with low bioactive factor delivery efficiency, difficulty crossing biological barriers, ineffective bioimaging, and unfavorable off-target effects that would otherwise impede the advancement of cardiovascular medicine. In particular, the control of inflammation and fibrogenesis, the encouragement of angiogenesis, and accelerated tissue regeneration are driving efforts to create more effective therapeutic and diagnostic solutions for clinical issues faced by MI treatment.
Myocardial Infarction (MI) Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the analysis, the global myocardial infarction (MI) therapeutics market is currently led by countries in the North American region, due to the increasing incidence of myocardial infarction (MI) in this region. Along with this, the hospital pharmacies segment is projected to lead the market due to the easy access and wide availability of hospitals, over the forecast period.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.20 billion |
| Market size value in 2031 | USD 3.36 billion |
| Growth Rate | 4.82% |
| Base year | 2023 |
| Forecast period | 2024–2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Myocardial Infarction (MI) Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Myocardial Infarction (MI) Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Myocardial Infarction (MI) Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Myocardial Infarction (MI) Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Myocardial Infarction (MI) Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Myocardial Infarction (MI) Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
